Phosphonated carbocyclic 2′-oxa-3′-azanucleosides as new antiretroviral agents

Journal of Medicinal Chemistry

Volumn 50, Issue 15, 2007, Pages 3747-3750

  Chiacchio, Ugo ^a   Rescifina, Antonio ^a   Iannazzo, Daniela ^b   Piperno, Anna ^b   Romeo, Roberto ^b   Borrello, Luisa ^a   Sciortino, Maria Teresa ^b   Balestrieri, Emanuela ^c   Macchi, Beatrice ^c   Mastino, Antonio ^b   Romeo, Giovanni ^b  

^a UNIVERSITY OF CATANIA   (Italy)

^b UNIVERSITY OF MESSINA   (Italy)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CARBOCYCLIC NUCLEOSIDE; PHOSPHONATED CARBOCYCLIC 2' OXA 3' AZANUCLEOSIDE; PHOSPHONIC ACID DERIVATIVE; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; DRUG EFFECT; DRUG STRUCTURE; DRUG SYNTHESIS; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; REACTION ANALYSIS; STRUCTURE ANALYSIS; VIRUS TRANSMISSION;

ANTI-RETROVIRAL AGENTS; AZA COMPOUNDS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; LEUKOCYTES, MONONUCLEAR; PHOSPHONIC ACIDS; PURINE NUCLEOSIDES; PYRIMIDINE NUCLEOSIDES; REVERSE TRANSCRIPTASE INHIBITORS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 34547595138     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm070285r     Document Type: Article

References (22)

1. (a) Jordheim, L. P.; Galmarini, C. M.; Dumontet, C. Recent Developments To Improve the Efficacy of Cytotoxic Nucleoside Analogues. Recent Pat. Anti-Cancer Drug Discovery 2006, 1, 163-170.
2. (b) Schinazi, R. F.; Hernandez-Santiago, B. I.; Hurwitz, S. J. Pharmacology of Current and Promising Nucleosides for the Treatment of Human Immunodeficiency Viruses. Antiviral Res. 2006, 71, 322-334.
3. (c) Michael, J. O. New Nucleoside Reverse Transcriptase Inhibitors for the Treatment of HIV Infections. Curr. Opin. Pharmacol. 2004, 4, 431-436.
4. (a) Choo, H.; Chen, X.; Yadav, V.; Wang, J.; Schinazi, R. F.; Chu, C. K. Synthesis and Anti-HIV Activity of D- and L-Thietanose Nucleosides. J. Med. Chem. 2006, 49, 1635-1647.
5. (b) Chiacchio, U.; Corsaro, A.; Iannazzo, D.; Piperno, A.; Pistara, V.; Rescifina, A.; Romeo, R.; Valveri, V.; Mastino, A.; Romeo, G. Enantioselective Syntheses and Cytotoxicity of N,O-Nucleosides. J. Med. Chem. 2003, 46, 3696-3702.
6. (c) Lee, Y.-S.; Hyean, K. B. Heterocyclic Nucleoside Analogues: Design and Synthesis of Antiviral, Modified Nucleosides Containing Isoxazole Heterocycles. Bioorg. Med. Chem. Lett. 2002, 12, 1395-1397.
7. Merino, P.; Franco, S.; Merchan, F. L.; Tejero, T. Recent Developments on Chemistry and Biological Activity of Nucleoside Analogues with an Extra Heteroatom in the Sugar Ring. Recent Res. Dev. Org. Chem. 2000, 4, 227-237.
8. Chiacchio, U.; Balestrieri, E.; Macchi, B.; Iannazzo, D.; Piperno, A.; Rescifina, A.; Romeo, R.; Saglimbeni, M.; Sciortino, M. T.; Valveri, V.; Mastino, A.; Romeo, G. Synthesis of Phosphonated Carbocyclic-2′-oxo- 3′-aza-nucleosides: Novel Inhibitors of Reverse Transcriptase. J. Med. Chem. 2005, 48, 1389-1394.
9. Perigaud, C.; Girardet, J. L.; Gosselin, G.; Imbach, J. L. Comments on Nucleotide Delivery Forms. In Advances in Antiviral Drug Design; De Clercq, E., Ed.; JAI Press: Greenwich, CT, 1995; Vol. 2, pp 167-172.
10. (a) Mitsuya, H.; Yarchoan, R.; Broder, S. Molecular Targets for Aids Therapy. Science 1990, 249, 1533-1544.
11. (b) De Clercq, E. HIV Resistance to Reverse Transcriptase Inhibitors. Biochem. Pharmacol. 1994, 47, 155-169.
12. (c) Katz, R. A.; Skalka, A. M. The Retroviral Enzymes. Annu. Rev. Biochem. 1994, 63, 133-173.
13. (d) Turner, B. G.; Summers, M. F. Structural Biology of HIV. J. Mol. Biol. 1999, 285, 1-32.
14. (e) Jonckheere, H.; Anne, J.; De Clercq, E. The HIV-1 Reverse Transcription (RT) Process as Target for RT Inhibitors. Med. Res. Rev. 2000, 20, 129-154.
15. Mulato, A. S.; Cherrington, J. M. Anti-HIV Activity of Adefovir PMEA and PMPA in Combination with Antiretroviral Compounds: In Vitro Analyses. Antiviral Res. 1997, 36, 91-97.
16. Chiacchio, U.; Corsaro, A.; Gumina G.; Rescifina, A.; Iannazzo, D.; Pipemo, A.; Romeo, R.; Romeo, G. Homochiral α-D- and β-D-Isoxazolidinylthymidines via 1,3-Dipolar Cycloaddition. J. Org. Chem. 1999, 64, 9321-9327.
17. Poiesz, B. J.; Ruscetti, F. W.; Reitz, M. S.; Kalyanaraman, V. S.; Gallo, R. C. Isolation of a New Type C Retrovirus (HTLV) in Primary Uncultured Cells of a Patient with Sezary T-Cell Leukaemia. Nature 1981, 294, 268-271.
18. Iannazzo, D.; Piperno, A.; Pistarà, V.; Rescifina, A.; Romeo, R. Modified nucleosides. A general and diastereoselective approach to N,O-psiconucleosides. Tetrahedron 2002, 58, 581-587.
19. Balestrieri, E.; Sciortino, M. T.; Mastino, A.; Macchi, B. Protective Effect of the Acyclic Nucleoside Phosphonate Tenofovir toward Human T-Cell Leukaemia/lymphotropic Virus Type 1 Infection of Human Peripheral Blood Mononuclear Cells in Vitro. Antiviral Res. 2005, 68, 154-162.
20. (a) Macchi, B.; Balestrieri, E.; Mastino, A. Effects of Nucleoside-Based Anti-Retroviral Chemotherapy on Human T-Cell Leukaemia/Lymphotropic Virus Type-1 (HTLV-1) Infection in Vitro. J. Antimicrob. Chemother. 2003, 51, 1327-1330.
21. (b) Balestrieri, E.; Forte, G.; Matteucci, C.; Mastino, A.; Macchi, B. Effect of Lamivudine on Transmission of Human T-Cell Lymphotropic Virus Type 1 to Adult Peripheral Blood Mononuclear Cells in Vitro. Antimicrob. Agents Chemother. 2002, 46, 3080-3083.
22. (c) Macchi, B.; Faraoni, I.; Zhang, J.; Grelli, S.; Favalli, C.; Mastino, A.; Bonmassar, E. AZT Inhibits the Transmission of Human T Cell Leukaemia/Lymphoma Virus Type I to Adult Peripheral Blood Mononuclear Cells in Vitro. J. Gen. Virol. 1997, 78, 1007-1016.